(Updated - July 3, 2025 7:39 AM EDT)Morgan Stanley analyst Sean Laaman assumes coverage on Zenas Biopharma (NASDAQ: ZBIO) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE